Production and launch of Favipiravir and Remdesivir in Actover Pharma group

October 20, 2020

Author: Acteropharma

With continuous monitoring of international research and protocols, it was suggested to produce drugs in the treatment of Covid-19 in the Actover group, as a pioneer in the production of drugs needed in COVID-19, the group unveiled two drugs, Remdesivir and Favipiravir. It should be noted that these two drugs have entered the official list of drugs in Iran.

Last News

Actero Support in Congress 1400

July 24, 2022

Author:

Acteropharma

Actero company’s social respomsibility of patient support in Hematology-Oncology Congress and Radiation Therapy Congress

Best of ASCO 2021

November 16, 2021

Author:

Acteropharma

The aforesaid seminar has been held for the first time in Iran with the hospitality of Isfahan city, with the cooperation of Radiation-Oncologists from all over of the country and Actero Pharma.

“Uro-Oncology Tumor board: Challenges of Prostate Cancer Treatment” (Semi-Virtual)

November 16, 2021

Author:

Acteropharma

Uro-Oncology research Center of Tehran University of Medical science, in cooperation with Actero Pharma has held a semi-virtual tumor board.